Zimmer Holdings (NY:ZBH)

88.29 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

3 Out-of-Favor Stocks We Approach with Caution

May 11, 2026

The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet...

Via StockStory

5 Revealing Analyst Questions From Zimmer Biomet’s Q1 Earnings Call

May 05, 2026

Zimmer Biomet’s first quarter of 2026 results exceeded Wall Street’s expectations for both revenue and non-GAAP earnings, but the market responded negatively...

Via StockStory

Topics Earnings

These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results ↗

April 29, 2026

Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported strong Q1 earnings, beating estimates and raising guidance. Analysts maintain mixed views on stock.

Via Benzinga

ZBH Q1 Deep Dive: Sales Force Changes, Tech Investments, and Margin Expansion Shape Outlook

April 29, 2026

Medical device company Zimmer Biomet (NYSE:ZBH) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 9.3% year on year to $2...

Via StockStory

Which S&P500 stocks have an unusual volume on Tuesday? ↗

April 28, 2026

Via Chartmill

Gapping S&P500 stocks in Tuesday's session ↗

April 28, 2026

Via Chartmill

Discover which S&P500 stocks are making waves on Tuesday. ↗

April 28, 2026

Via Chartmill

What's going on in today's session: S&P500 movers ↗

April 28, 2026

Via Chartmill

Zimmer Biomet (ZBH) Q1 2026 Earnings Transcript ↗

April 28, 2026

Zimmer Biomet (ZBH) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics World Trade

Zimmer Biomet’s (NYSE:ZBH) Q1 CY2026 Sales Beat Estimates

April 28, 2026

Medical device company Zimmer Biomet (NYSE:ZBH) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 9.3% year on year to $2.09 b...

Via StockStory

Topics Earnings

What To Expect From Zimmer Biomet’s (ZBH) Q1 Earnings

April 26, 2026

Medical device company Zimmer Biomet (NYSE:ZBH) will be announcing earnings results this Tuesday before market hours. Here’s what investors should know. Zimm...

Via StockStory

Topics Artificial Intelligence

1 S&P 500 Stock to Own for Decades and 2 We Find Risky

April 24, 2026

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...

Via StockStory

Topics Stocks

3 Mid-Cap Stocks We Keep Off Our Radar

April 23, 2026

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe...

Via StockStory

Topics Bonds

Zimmer Biomet (ZBH) Q4 2024 Earnings Transcript ↗

April 22, 2026

Zimmer Biomet (ZBH) Q4 2024 Earnings Transcript

Via The Motley Fool

QSM Asset Management Loads Up 611,000 Mobileye Shares ↗

April 16, 2026

Mobileye develops advanced driver assistance and autonomous driving technologies for global automotive manufacturers and suppliers.

Via The Motley Fool

Topics Economy Regulatory Compliance Supply Chain

A Fund Just Bet $5.7 Million on Robert Half -- Is the Staffing Sector Due for a Rebound? ↗

April 15, 2026

Robert Half Inc. provides staffing and risk consulting solutions globally to employers across diverse industries.

Via The Motley Fool

Topics Regulatory Compliance

QSM Asset Management Bets on Beaten-Down Manpower Group With New $5.9 Million Stake in ManpowerGroup ↗

April 15, 2026

ManpowerGroup provides staffing and HR solutions worldwide, serving clients in 75 countries.

Via The Motley Fool

Topics Regulatory Compliance

MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat

April 14, 2026

In a resounding display of corporate resilience, Johnson & Johnson (NYSE:JNJ) reported first-quarter 2026 financial results that surpassed Wall Street expectations, signaling a successful navigation of...

Via MarketMinute

Topics Bankruptcy Earnings Economy

Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis Widens

April 13, 2026

CANTON, Mass. — In a milestone development for the regenerative medicine sector, Organogenesis Holdings Inc. (Nasdaq: ORGO) announced today that it has successfully concluded a pivotal Type B meeting...

Via MarketMinute

3 Cash-Producing Stocks We Keep Off Our Radar

April 13, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Via StockStory

3 Value Stocks We Find Risky

April 03, 2026

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the...

Via StockStory

Topics Economy

These S&P500 stocks that are showing activity before the opening bell on Monday. ↗

March 30, 2026

Via Chartmill

Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6? ↗

March 20, 2026

Organon & Co. develops branded and biosimilar therapies with a focus on women’s health and specialty pharmaceuticals.

Via The Motley Fool

Surgical Equipment & Consumables - Diversified Stocks Q4 In Review: Zimmer Biomet (NYSE:ZBH) Vs Peers

March 18, 2026

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a...

Via StockStory

Topics Artificial Intelligence Economy World Trade

Stryker Corporation (SYK): Navigating Innovation and Resilience in the Wake of a Digital Crisis

March 16, 2026

As of March 16, 2026, the medical technology landscape is grappling with a stark reminder of the vulnerabilities inherent in the digital shift of healthcare. Stryker Corporation (NYSE: SYK), a global...

Via Finterra

Topics Earnings Economy Hacking

3 Healthcare Stocks We Think Twice About

March 11, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...

Via StockStory

3 Reasons to Avoid ZBH and 1 Stock to Buy Instead

February 19, 2026

Over the past six months, Zimmer Biomet’s stock price fell to $99.27. Shareholders have lost 6.1% of their capital, which is disappointing considering the S&P 500 has climbed by 7.6%. This might have...

Via StockStory

Topics Stocks

3 Reasons to Avoid ZBH and 1 Stock to Buy Instead

February 18, 2026

Over the last six months, Zimmer Biomet’s shares have sunk to $98.28, producing a disappointing 5.8% loss - a stark contrast to the S&P 500’s 6.7% gain. This may have investors wondering how to...

Via StockStory

Topics Stocks

The Top 5 Analyst Questions From Zimmer Biomet’s Q4 Earnings Call

February 17, 2026

Zimmer Biomet’s fourth quarter results were greeted positively by the market, with management crediting strong execution in the U.S. and robust demand for recently launched products as key drivers. CEO...

Via StockStory

Topics Earnings

A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH ↗

February 12, 2026

Via MarketBeat

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.